ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

NCI Human Tissue Network Resources Available For Research

January 24, 1997

NIH appoints panel to review conflict of interest rules.

February 27, 2004

New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed

January 27, 1989

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

GP Amendment To Waxman Bill Would Leave Dollar Levels The Same But would Drop Centers Line Item

August 5, 1983